#United States #California #Securities Fraud #Hims & Hers #Hims

Hims & Hers Health Class Action Update

In an unfolding legal matter, Hims & Hers Health, Inc. (NYSE: HIMS) is currently facing a securities fraud class action lawsuit. This lawsuit was filed on behalf of investors who acquired HIMS securities between August 4, 2025, and July 29, 2026. This class can now take action as they may be entitled to recover damages resulting from allegations of misleading information provided by the company.

The law firm Kessler Topaz Meltzer Check, LLP, which is spearheading this case, asserts that the defendants failed to disclose significant information regarding the company’s operations and business practices that ultimately misled investors. Key accusations documented in the court filings charge Hims with serious allegations, including sharing sensitive consumer health information with third-party advertisers without proper consent.

Allegations Against Hims

The lawsuit lays out several key points of concern:

1. Misleading Statements: The company allegedly made materially false representations concerning its privacy practices and neglected to inform investors about the ramifications of these practices.
2. Regulatory Scrutiny: It is claimed that Hims faced scrutiny from regulatory bodies, including the Federal Trade Commission (FTC), regarding its handling of consumer health information. The FTC recently filed a complaint that emphasizes Hims' unlawful sharing of private health information to third-party platforms like Meta Platforms and Snap.
3. Negative Impact on Stocks: Following the FTC's actions, HIMS's stock price experienced a significant decline, falling by over 14% on July 29, 2026. This rapid drop highlights the immediate impact such allegations can have on investor confidence and company valuations.
4. Investor Recourse: Investors who suffered losses due to this situation are encouraged to take steps to protect their rights. They can file for lead plaintiff status before the upcoming deadline of November 2, 2026.

What Should Affected Investors Do Now?

For those who invested in HIMS during the specified period and are concerned about the impact of these allegations, it is crucial to act quickly. Some actionable steps include:

• - Contact Legal Counsel: Investors wanting to understand their rights and options can reach out to Kessler Topaz Meltzer Check, LLP for a free case evaluation.
• - Consider Lead Plaintiff Status: Becoming a lead plaintiff allows investors with the largest financial stake to represent the collective interests of all affected stakeholders.
• - Stay Informed: Keeping track of updates related to the case and any developments with Hims will be essential for all investors involved.

Conclusion

As Hims & Hers Health navigates these turbulent legal waters, the outcome of this class action could be pivotal for both the company and its investors. Transparency and accountability will be critical components moving forward, as investors expect clarity surrounding Hims' business practices and privacy policies. It will be informative to observe the company's response to these accusations and how it plans to rebuild trust among its stakeholders.

For further information, investors may visit the Kessler Topaz Meltzer Check, LLP website or contact attorney Jonathan Naji at (484) 270-1453 to discuss eligibility and recovery options.